GenMark Diagnostics Stock News

GenMark intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering. Cowen and William Blair are acting as joint

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech Stocks Hitting 52-week Highs May 5) • Adverum Biotechnologies...

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks hitting 52-week highs May 5.) * Arcturus Therapeutics Ltd (NASDAQ: ARCT) (announced

Ladies and gentlemen, thank you for standing by, and welcome to the GenMark Diagnostics First Quarter Earnings Conference Call. Before we begin, I would like to inform you that certain statements mad

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs May 5.) Arcturus Therapeutics Ltd (...

GenMark Diagnostics (GNMK) delivered earnings and revenue surprises of 75.00% and 0.11%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

* GENMARK DIAGNOSTICS INC - SCOTT MENDEL HAS BEEN APPOINTED PRESIDENT AND CHIEF EXECUTIVE OFFICER EFFECTIVE IMMEDIATELY Source text for Eikon: Further company coverage:

* Q1 EARNINGS PER SHARE ESTIMATE $-0.14 -- REFINITIV IBES DATA

CARLSBAD, Calif., May 04, 2020 -- GenMark Diagnostics, Inc. ("GenMark" or the "Company") (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing.

CARLSBAD, Calif., May 04, 2020 -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced.

Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...

Anyone researching GenMark Diagnostics, Inc. (NASDAQ:GNMK) might want to consider the historical volatility of the...

Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29)• Arvinas Inc (NASDAQ: ARVN) • Biondvax Pharmaceu